One of our younger Principal Investigators, James had cystic fibrosis and his research interests focused on lung biology and respiratory distress.

His HRB award, due to start in January 2018, was  ‘Development of a Nebulised Cell Based Therapy for Acute Respiratory Distress Syndrome’. The research work he proposed will be carried on by his co-applicants who share his commitment to finding solutions for acute lung conditions.